| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | PRL-3 Inhibitor I | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.001 | 1 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | -0.00099 | 1 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | 0.00076 | 1 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00064 | 1 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.00059 | 1 |